{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:01:07Z","timestamp":1780560067467,"version":"3.54.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009104","name":"Department of Health Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","award":["111-5316-8707\/2k24\/1"],"award-info":[{"award-number":["111-5316-8707\/2k24\/1"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008812","name":"Defence Science and Technology Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001332","name":"Council for Scientific and Industrial Research, South Africa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2020\/002630"],"award-info":[{"award-number":["CRG\/2020\/002630"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000964","name":"Arthritis National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"ICMR","doi-asserted-by":"publisher","award":["IIRP-2023-5527"],"award-info":[{"award-number":["IIRP-2023-5527"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jmgm.2026.109394","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:59:57Z","timestamp":1774929597000},"page":"109394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of novel quinoxaline linked oxadiazole derivatives as \u03b1-glucosidase inhibitors through homology modelling based in silico screening and in vitro evaluation"],"prefix":"10.1016","volume":"146","author":[{"given":"Ojasvi","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tathagata","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gita","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2026.109394_bib1","unstructured":"Nadhiya J., Vijayalakshmi M., Showbharnikhaa S., A brief review on diabetes mellitus, J. Pharma Insights and Res. 2 (1) 117-121,."},{"key":"10.1016\/j.jmgm.2026.109394_bib2","doi-asserted-by":"crossref","unstructured":"Gupta O., Chawla G., Pradhan T., 1, 3, 4-oxadiazole scaffold in antidiabetic drug discovery: an overview, Mini Rev. Med. Chem. 24 (20) 1800-1821, https:\/\/doi.org\/10.2174\/0113895575298181240410041029,.","DOI":"10.2174\/0113895575298181240410041029"},{"key":"10.1016\/j.jmgm.2026.109394_bib3","series-title":"Diabetes Around the World IDF Data","year":"2025"},{"key":"10.1016\/j.jmgm.2026.109394_bib4","series-title":"Diabetes WHO Data","year":"2025"},{"key":"10.1016\/j.jmgm.2026.109394_bib5","doi-asserted-by":"crossref","unstructured":"Gupta O., Pradhan T., Chawla G., Structural and functional insights into PPAR-\u03b3: review of its potential and drug design innovations for the development of antidiabetic agents, Eur. J. Med. Chem. 118264, https:\/\/doi.org\/10.1016\/j.ejmech.2025.118264,.","DOI":"10.1016\/j.ejmech.2025.118264"},{"key":"10.1016\/j.jmgm.2026.109394_bib6","doi-asserted-by":"crossref","unstructured":"Sharma A., et al., CADD based designing and biological evaluation of novel triazole based thiazolidinedione coumarin hybrids as antidiabetic agent, Sci. Rep. 15 (1) 4302, https:\/\/doi.org\/10.1038\/s41598-025-88944-y,.","DOI":"10.1038\/s41598-025-88944-y"},{"key":"10.1016\/j.jmgm.2026.109394_bib7","doi-asserted-by":"crossref","unstructured":"Tegegne B. A., et al., A critical review on diabetes mellitus type 1 and type 2 management approaches: from lifestyle modification to current and novel targets and therapeutic agents, Front. Endocrinol. 15 1440456, https:\/\/doi.org\/10.3389\/fendo.2024.1440456,.","DOI":"10.3389\/fendo.2024.1440456"},{"key":"10.1016\/j.jmgm.2026.109394_bib8","doi-asserted-by":"crossref","unstructured":"Scheen A. J., Is there a role for \u03b1-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?, Drugs 63 (10) 933-951, https:\/\/doi.org\/10.2165\/00003495-200363100-00002,.","DOI":"10.2165\/00003495-200363100-00002"},{"key":"10.1016\/j.jmgm.2026.109394_bib9","doi-asserted-by":"crossref","unstructured":"Kumar S., Narwal S., Kumar V., Prakash O., \u03b1-glucosidase inhibitors from plants: a natural approach to treat diabetes, Pharmacogn. Rev. 5 (9) 19, https:\/\/doi.org\/10.4103\/0973-7847.79096,.","DOI":"10.4103\/0973-7847.79096"},{"key":"10.1016\/j.jmgm.2026.109394_bib10","doi-asserted-by":"crossref","unstructured":"Prasetyanti I. K., ADMET prediction and in silico analysis of mangostin derivatives and sinensetin on maltase-glucoamylase target for searching anti-diabetes drug candidates, Pharmacogn. J. 13 (4), https:\/\/doi.org\/10.5530\/pj.2021.13.113,.","DOI":"10.5530\/pj.2021.13.113"},{"key":"10.1016\/j.jmgm.2026.109394_bib11","doi-asserted-by":"crossref","unstructured":"Sim L., et al., Structural basis for substrate selectivity in human maltase-glucoamylase and sucrase-isomaltase N-terminal domains, J. Biol. Chem. 285 (23) 17763-17770, https:\/\/doi.org\/10.1074\/jbc.M109.078980,.","DOI":"10.1074\/jbc.M109.078980"},{"key":"10.1016\/j.jmgm.2026.109394_bib12","series-title":"Natural Products as Enzyme Inhibitors: an Industrial Perspective","first-page":"269","article-title":"\u03b1-Glucosidase inhibitors for diabetes\/blood sugar regulation","author":"Bhatnagar","year":"2022"},{"key":"10.1016\/j.jmgm.2026.109394_bib13","doi-asserted-by":"crossref","unstructured":"Shayegan N., et al., Design, synthesis, and in silico studies of benzimidazole bearing phenoxyacetamide derivatives as \u03b1-glucosidase and \u03b1-amylase inhibitors, J. Mol. Struct. 1268 (2022\/11\/15\/) 133650, https:\/\/doi.org\/10.1016\/j.molstruc.2022.133650,.","DOI":"10.1016\/j.molstruc.2022.133650"},{"key":"10.1016\/j.jmgm.2026.109394_bib14","doi-asserted-by":"crossref","unstructured":"Singh A., et al., Discovery of triazole tethered thymol\/carvacrol-coumarin hybrids as new class of \u03b1-glucosidase inhibitors with potent in vivo antihyperglycemic activities, Eur. J. Med. Chem. 263 115948, https:\/\/doi.org\/10.1016\/j.ejmech.2023.115948,.","DOI":"10.1016\/j.ejmech.2023.115948"},{"key":"10.1016\/j.jmgm.2026.109394_bib15","doi-asserted-by":"crossref","unstructured":"Zhang L., et al., Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: a systematic review and meta-analysis, Sci. Rep. 6 (1) 32649, https:\/\/doi.org\/10.1038\/srep32649,.","DOI":"10.1038\/srep32649"},{"key":"10.1016\/j.jmgm.2026.109394_bib16","doi-asserted-by":"crossref","unstructured":"Dirir A. M., Daou M., Yousef A. F., Yousef L. F., A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes, Phytochem. Rev. 21 (4) 1049-1079, https:\/\/doi.org\/10.1007\/s11101-021-09773-1,.","DOI":"10.1007\/s11101-021-09773-1"},{"key":"10.1016\/j.jmgm.2026.109394_bib17","doi-asserted-by":"crossref","unstructured":"Lang D. K., Kaur R., Arora R., Saini B., Arora S., Nitrogen-containing heterocycles as anticancer agents: an overview, Anti Cancer Agents Med. Chem. 20 (18) 2150-2168, https:\/\/doi.org\/10.2174\/1871520620666200705214917,.","DOI":"10.2174\/1871520620666200705214917"},{"key":"10.1016\/j.jmgm.2026.109394_bib18","doi-asserted-by":"crossref","unstructured":"Kumar A., et al., Nitrogen containing heterocycles as anticancer agents: a medicinal chemistry perspective, Pharmaceuticals 16 (2) 299, https:\/\/doi.org\/10.3390\/ph16020299,.","DOI":"10.3390\/ph16020299"},{"key":"10.1016\/j.jmgm.2026.109394_bib19","doi-asserted-by":"crossref","unstructured":"Yu H., Xu F., Advances in the synthesis of nitrogen-containing heterocyclic compounds by in situ benzyne cycloaddition, RSC Adv. 13 (12) 8238-8253, https:\/\/doi.org\/10.1039\/D3RA00400G,.","DOI":"10.1039\/D3RA00400G"},{"key":"10.1016\/j.jmgm.2026.109394_bib20","doi-asserted-by":"crossref","unstructured":"Marshall C. M., Federice J. G., Bell C. N., Cox P. B., Njardarson J. T., An update on the nitrogen heterocycle compositions and properties of US FDA-approved pharmaceuticals (2013\u20132023), J. Med. Chem. 67 (14) 11622-11655, https:\/\/doi.org\/10.1021\/acs.jmedchem.4c01122,.","DOI":"10.1021\/acs.jmedchem.4c01122"},{"key":"10.1016\/j.jmgm.2026.109394_bib21","doi-asserted-by":"crossref","unstructured":"Pereira J. A., et al., Quinoxaline, its derivatives and applications: a state of the art review, Eur. J. Med. Chem. 97 664-672, https:\/\/doi.org\/10.1016\/j.ejmech.2014.06.058,.","DOI":"10.1016\/j.ejmech.2014.06.058"},{"key":"10.1016\/j.jmgm.2026.109394_bib22","doi-asserted-by":"crossref","unstructured":"Wang J.-J., Sun W., Jia W.-D., Bian M., Yu L.-J., Research progress on the synthesis and pharmacology of 1, 3, 4-oxadiazole and 1, 2, 4-oxadiazole derivatives: a mini review, J. Enzym. Inhib. Med. Chem. 37 (1) 2304-2319, https:\/\/doi.org\/10.1080\/14756366.2022.2115036,.","DOI":"10.1080\/14756366.2022.2115036"},{"key":"10.1016\/j.jmgm.2026.109394_bib23","doi-asserted-by":"crossref","unstructured":"Chaudhary T., Upadhyay P. K., A review on novel synthesis approaches and biological activities of 1, 2, 4-oxadiazole and 1, 3, 4-oxadiazole tailored compounds, Curr. Org. Synth. 19 (6) 731-747, https:\/\/doi.org\/10.2174\/1570179419666220216122238,.","DOI":"10.2174\/1570179419666220216122238"},{"key":"10.1016\/j.jmgm.2026.109394_bib24","doi-asserted-by":"crossref","unstructured":"Bhat N., Kumar A., Kumar P., Pai A., A comprehensive review on the antidiabetic activity of oxadiazole derivatives, Res. J. Pharm. Technol. 16 (6) 2771-2775, https:\/\/doi.org\/0.52711\/0974-360X.2023.00455,.","DOI":"10.52711\/0974-360X.2023.00455"},{"key":"10.1016\/j.jmgm.2026.109394_bib25","doi-asserted-by":"crossref","unstructured":"Kothari M., Kannan K., Sahadevan R., Sadhukhan S., Novel molecular hybrids of EGCG and quinoxaline: potent multi-targeting antidiabetic agents that inhibit \u03b1-glucosidase, \u03b1-amylase, and oxidative stress, Int. J. Biol. Macromol. 263 130175, https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.130175,.","DOI":"10.1016\/j.ijbiomac.2024.130175"},{"key":"10.1016\/j.jmgm.2026.109394_bib26","doi-asserted-by":"crossref","unstructured":"Ragab A., et al., Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro \u03b1\u2010glucosidase, \u03b1\u2010amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation, Drug Dev. Res. 85 (4) e22216, https:\/\/doi.org\/10.1002\/ddr.22216,.","DOI":"10.1002\/ddr.22216"},{"key":"10.1016\/j.jmgm.2026.109394_bib27","doi-asserted-by":"crossref","unstructured":"Xiao D., et al., Identification of 1, 3, 4-oxadiazolyl-containing \u03b2-carboline derivatives as novel \u03b1-glucosidase inhibitors with antidiabetic activity, Eur. J. Med. Chem. 261 115795, https:\/\/doi.org\/10.1016\/j.ejmech.2023.115795,.","DOI":"10.1016\/j.ejmech.2023.115795"},{"key":"10.1016\/j.jmgm.2026.109394_bib28","doi-asserted-by":"crossref","unstructured":"Ibrahim M. K., et al., Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPAR\u03b3 and SUR agonists, Bioorg. Med. Chem. 25 (4) 1496-1513, https:\/\/doi.org\/10.1016\/j.bmc.2017.01.015,.","DOI":"10.1016\/j.bmc.2017.01.015"},{"key":"10.1016\/j.jmgm.2026.109394_bib29","doi-asserted-by":"crossref","unstructured":"Syam Y. M., et al., New quinoxaline compounds as DPP-4 inhibitors and hypoglycemics: design, synthesis, computational and bio-distribution studies, RSC Adv. 11 (58) 36989-37010, https:\/\/doi.org\/10.1039\/D1RA06799K,.","DOI":"10.1039\/D1RA06799K"},{"key":"10.1016\/j.jmgm.2026.109394_bib30","doi-asserted-by":"crossref","unstructured":"Chawla G., Gupta O., Pradhan T., A review on multipurpose potential of bioactive heterocycle quinoxaline, ChemistrySelect 8 (29) e202301401, https:\/\/doi.org\/10.1002\/slct.202301401,.","DOI":"10.1002\/slct.202301401"},{"key":"10.1016\/j.jmgm.2026.109394_bib31","unstructured":"Irfan A., et al., A review on the therapeutic potential of quinoxaline derivatives, World J. Pharmaceut. Res. 6 47-68, https:\/\/doi.org\/10.20959\/wjpr201713-9878,."},{"key":"10.1016\/j.jmgm.2026.109394_bib32","doi-asserted-by":"crossref","unstructured":"Anastasiou I. A., et al., The effect of oxidative stress and antioxidant therapies on pancreatic \u03b2-cell dysfunction: results from in vitro and in vivo studies, Curr. Med. Chem. 28 (7) 1328-1346, https:\/\/doi.org\/10.2174\/0929867327666200526135642,.","DOI":"10.2174\/0929867327666200526135642"},{"key":"10.1016\/j.jmgm.2026.109394_bib33","doi-asserted-by":"crossref","unstructured":"Newsholme P., Keane K. N., Carlessi R., Cruzat V., Oxidative stress pathways in pancreatic \u03b2-cells and insulin-sensitive cells and tissues: importance to cell metabolism, function, and dysfunction, Am. J. Physiol. Cell Physiol. 317 (3) C420-C433, https:\/\/doi.org\/10.1152\/ajpcell.00141.2019,.","DOI":"10.1152\/ajpcell.00141.2019"},{"key":"10.1016\/j.jmgm.2026.109394_bib34","doi-asserted-by":"crossref","unstructured":"Montonen J., Knekt P., Jarvinen R., Reunanen A., Dietary antioxidant intake and risk of type 2 diabetes, Diabetes Care 27 (2) 362-366, https:\/\/doi.org\/10.2337\/diacare.27.2.362,.","DOI":"10.2337\/diacare.27.2.362"},{"key":"10.1016\/j.jmgm.2026.109394_bib35","doi-asserted-by":"crossref","unstructured":"Khan H., et al., Exploring 1, 3, 4-Oxadiazole derivatives of 3, 4-Dihydroxyphenylacetic acid as potent \u03b1-glucosidase inhibitors: synthesis, structure-activity relationship, molecular docking, and DFT studies, J. Mol. Struct. 1327 141211, https:\/\/doi.org\/10.1016\/j.molstruc.2024.141211,.","DOI":"10.1016\/j.molstruc.2024.141211"},{"key":"10.1016\/j.jmgm.2026.109394_bib36","doi-asserted-by":"crossref","unstructured":"Luczynski M., Kudelko A., Synthesis and biological activity of 1, 3, 4-oxadiazoles used in medicine and agriculture, Appl. Sci. 12 (8) 3756, https:\/\/doi.org\/10.3390\/app12083756,.","DOI":"10.3390\/app12083756"},{"key":"10.1016\/j.jmgm.2026.109394_bib37","doi-asserted-by":"crossref","unstructured":"Acar \u00c7evik U., et al., New benzimidazole\u2010oxadiazole derivatives: synthesis, \u03b1\u2010glucosidase, \u03b1\u2010amylase activity, and molecular modeling studies as potential antidiabetic agents, Arch. Pharmazie 356 (5) 2200663, https:\/\/doi.org\/10.1002\/ardp.202200663,.","DOI":"10.1002\/ardp.202200663"},{"key":"10.1016\/j.jmgm.2026.109394_bib38","doi-asserted-by":"crossref","unstructured":"Gohar N. A., et al., Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting \u03b1-amylase, and \u03b1-glucosidase: synthesis, molecular docking, and ADMET studies, J. Enzym. Inhib. Med. Chem. 39 (1) 2367128, https:\/\/doi.org\/10.1080\/14756366.2024.2367128,.","DOI":"10.1080\/14756366.2024.2367128"},{"key":"10.1016\/j.jmgm.2026.109394_bib39","doi-asserted-by":"crossref","unstructured":"Radzuan S. N. M., et al., Synthesis, biological activities, and evaluation molecular docking-dynamics studies of new phenylisoxazole quinoxalin-2-amine hybrids as potential \u03b1-amylase and \u03b1-glucosidase inhibitors, RSC Adv. 14 (11) 7684-7698, https:\/\/doi.org\/10.1039\/D3RA08642A,.","DOI":"10.1039\/D3RA08642A"},{"key":"10.1016\/j.jmgm.2026.109394_bib40","doi-asserted-by":"crossref","unstructured":"Missioui M., et al., Greener pastures in evaluating antidiabetic drug for a quinoxaline derivative: synthesis, characterization, molecular docking, in vitro and HSA\/DFT\/XRD studies, Arab. J. Chem. 15 (6) 103851, https:\/\/doi.org\/10.1016\/j.arabjc.2022.103851,.","DOI":"10.1016\/j.arabjc.2022.103851"},{"key":"10.1016\/j.jmgm.2026.109394_bib41","doi-asserted-by":"crossref","unstructured":"Missioui M., et al., Novel antioxidant quinoxaline derivative: synthesis, crystal structure, theoretical studies, antidiabetic activity and molecular docking study, J. Mol. Struct. 1239 130484, https:\/\/doi.org\/10.1016\/j.molstruc.2021.130484,.","DOI":"10.1016\/j.molstruc.2021.130484"},{"key":"10.1016\/j.jmgm.2026.109394_bib42","doi-asserted-by":"crossref","unstructured":"Alasmary F. A. S., et al., Synthesis, molecular modelling, and biological evaluation of novel quinoxaline derivatives for treating type II diabetes, J. Enzym. Inhib. Med. Chem. 39 (1) 2395985, https:\/\/doi.org\/10.1080\/14756366.2024.2395985,.","DOI":"10.1080\/14756366.2024.2395985"},{"key":"10.1016\/j.jmgm.2026.109394_bib43","doi-asserted-by":"crossref","unstructured":"Settypalli T., et al., Design, synthesis, in silico docking studies and biological evaluation of novel quinoxaline-hydrazide hydrazone-1, 2, 3-triazole hybrids as \u03b1-glucosidase inhibitors and antioxidants, New J. Chem. 43 (38) 15435-15452, https:\/\/doi.org\/10.1039\/C9NJ02580D,.","DOI":"10.1039\/C9NJ02580D"},{"key":"10.1016\/j.jmgm.2026.109394_bib44","doi-asserted-by":"crossref","unstructured":"Srinivasa M. G., et al., Novel hybrids of thiazolidinedione-1, 3, 4-oxadiazole derivatives: synthesis, molecular docking, MD simulations, ADMET study, in vitro, and in vivo anti-diabetic assessment, RSC Adv. 13 (3) 1567-1579, https:\/\/doi.org\/10.1039\/D2RA07247E,.","DOI":"10.1039\/D2RA07247E"},{"key":"10.1016\/j.jmgm.2026.109394_bib45","doi-asserted-by":"crossref","unstructured":"Prakash O., Kumar M., Kumar R., Sharma C., Aneja K., Hypervalent iodine (III) mediated synthesis of novel unsymmetrical 2, 5-disubstituted 1, 3, 4-oxadiazoles as antibacterial and antifungal agents, Eur. J. Med. Chem. 45 (9) 4252-4257, https:\/\/doi.org\/10.1016\/j.ejmech.2010.06.023,.","DOI":"10.1016\/j.ejmech.2010.06.023"},{"key":"10.1016\/j.jmgm.2026.109394_bib46","doi-asserted-by":"crossref","unstructured":"Farghaly A.-R., et al., Synthesis, antitumor activity, antimicrobial evaluation and molecular docking studies of some hydrazone, 1, 3, 4-oxadiazole, 1, 2, 4-triazole and pyrazole derivatives bearing nicotinoyl moiety, Results Chem. 7 101474, https:\/\/doi.org\/10.1016\/j.rechem.2024.101474,.","DOI":"10.1016\/j.rechem.2024.101474"},{"key":"10.1016\/j.jmgm.2026.109394_bib47","doi-asserted-by":"crossref","unstructured":"Park H., et al., Discovery of novel \u03b1-glucosidase inhibitors based on the virtual screening with the homology-modeled protein structure, Bioorg. Med. Chem. 16 (1) 284-292, https:\/\/doi.org\/10.1016\/j.bmc.2007.09.036,.","DOI":"10.1016\/j.bmc.2007.09.036"},{"key":"10.1016\/j.jmgm.2026.109394_bib48","doi-asserted-by":"crossref","unstructured":"Deng S., Li A., Zhang Y., Discovery of the new alpha-glucosidase inhibitor with therapeutic potential in type 2 diabetes mellitus by a novel high-throughput virtual screening and free energy evaluation, J. Mol. Graph. Model. 121 108447, https:\/\/doi.org\/10.1016\/j.jmgm.2023.108447,.","DOI":"10.1016\/j.jmgm.2023.108447"},{"key":"10.1016\/j.jmgm.2026.109394_bib49","doi-asserted-by":"crossref","unstructured":"Zonoubi A., Cn P., D Visaga Perumal Z., In silico analysis of active constituents of silymarin as \u03b1lpha-glucosidase enzyme inhibitors in type 2 diabetes mellitus, Asian J. Pharmaceut. Clin. Res. 9 225-229, https:\/\/doi.org\/10.22159\/ajpcr.2019.v12i9.34460,.","DOI":"10.22159\/ajpcr.2019.v12i9.34460"},{"key":"10.1016\/j.jmgm.2026.109394_bib50","doi-asserted-by":"crossref","unstructured":"Luthra T., Agarwal R., Estari M., Adepally U., Sen S., A novel library of-arylketones as potential inhibitors of \u03b1-glucosidase: their design, synthesis, in vitro and in vivo studies, Sci. Rep. 7 (1) 13246, https:\/\/doi.org\/10.1038\/s41598-017-13798-y,.","DOI":"10.1038\/s41598-017-13798-y"},{"issue":"2","key":"10.1016\/j.jmgm.2026.109394_bib51","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s12010-022-04190-2","article-title":"Identification of selective PPAR-\u03b3 modulators by combining pharmacophore modeling, molecular docking, and adipogenesis assay","volume":"195","author":"Li","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.jmgm.2026.109394_bib52","doi-asserted-by":"crossref","unstructured":"To D.-C., et al., On the inhibitability of natural products isolated from Tetradium ruticarpum towards tyrosine phosphatase 1B (PTP1B) and \u03b1-glucosidase (3W37): an in vitro and in silico study, Molecules 26 (12) 3691, https:\/\/doi.org\/10.3390\/molecules26123691,.","DOI":"10.3390\/molecules26123691"},{"key":"10.1016\/j.jmgm.2026.109394_bib53","article-title":"Screening of potential breast cancer inhibitors through molecular docking and molecular dynamics simulation","volume":"1","author":"Pandi","year":"2022","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jmgm.2026.109394_bib54","doi-asserted-by":"crossref","unstructured":"Genheden S., Ryde U., The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities, Expet Opin. Drug Discov. 10 (5) 449-461, https:\/\/doi.org\/10.1517\/17460441.2015.1032936,.","DOI":"10.1517\/17460441.2015.1032936"},{"key":"10.1016\/j.jmgm.2026.109394_bib55","doi-asserted-by":"crossref","unstructured":"Sun H., Li Y., Tian S., Xu L., Hou T., Assessing the performance of MM\/PBSA and MM\/GBSA methods. 4. Accuracies of MM\/PBSA and MM\/GBSA methodologies evaluated by various simulation protocols using PDBbind data set, Phys. Chem. Chem. Phys. 16 (31) 16719-16729, https:\/\/doi.org\/10.1039\/c4cp01388c,.","DOI":"10.1039\/C4CP01388C"},{"key":"10.1016\/j.jmgm.2026.109394_bib56","doi-asserted-by":"crossref","unstructured":"Pradhan T., Gupta O., Chawla G., Identification of novel thiazolidine-4-one based hits as potential PPAR\u03b3 modulators through in silico workflow and validation through in vitro studies, J. Mol. Struct. 1339 142391, https:\/\/doi.org\/10.1016\/j.molstruc.2025.142391,.","DOI":"10.1016\/j.molstruc.2025.142391"},{"key":"10.1016\/j.jmgm.2026.109394_bib57","doi-asserted-by":"crossref","unstructured":"Bourass M., et al., DFT and TD-DFT calculation of new thienopyrazine-based small molecules for organic solar cells, Chem. Cent. J. 10 1-11, https:\/\/doi.org\/10.1186\/s13065-016-0216-6,.","DOI":"10.1186\/s13065-016-0216-6"},{"key":"10.1016\/j.jmgm.2026.109394_bib58","doi-asserted-by":"crossref","unstructured":"Kumar V., Jangid K., Kumar N., Kumar V., Kumar V., 3D-QSAR-based pharmacophore modelling of quinazoline derivatives for the identification of acetylcholinesterase inhibitors through virtual screening, molecular docking, molecular dynamics and DFT studies, J. Biomol. Struct. Dyn. 1-15, https:\/\/doi.org\/10.1080\/07391102.2024.2313157,.","DOI":"10.1080\/07391102.2024.2313157"},{"key":"10.1016\/j.jmgm.2026.109394_bib59","doi-asserted-by":"crossref","DOI":"10.1007\/s11030-025-11395-0","article-title":"Rational in silico design of PPAR\u03b3 agonists for type 2 diabetes: an integrated study using pharmacophore modeling, 3D-QSAR, molecular docking, MD simulations, DFT, and toxicity prediction","author":"Pradhan","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.jmgm.2026.109394_bib60","unstructured":"Kumar A., et al., Synthesis, antiinflammatory and antimicrobial activities of new hydrazone and quinoxaline derivatives, Int. J. Chemtech. Res. 1 (4) 1177-1181,."},{"key":"10.1016\/j.jmgm.2026.109394_bib61","doi-asserted-by":"crossref","unstructured":"Haripriya V., Eppakayala L., Chary M. T., ChemInform abstract: a facile synthesis of 3-Hydroxy-N-(4-oxo-2-arylthiazolidin-3-yl)quinoxaline-2-carboxamides and N-(3-Chloro-2-oxo-4-arylazetidin-1-yl) -3-hydroxyquinoxaline-2-carboxamides, ChemInform 53 (09\/15) 1222-1225, https:\/\/doi.org\/10.1002\/chin.201511241,.","DOI":"10.1002\/chin.201511241"},{"key":"10.1016\/j.jmgm.2026.109394_bib62","doi-asserted-by":"crossref","unstructured":"El\u2010Zahabi H. S., Synthesis, characterization, and biological evaluation of some novel quinoxaline derivatives as antiviral agents, Arch. Pharmazie 350 (5) 1700028, https:\/\/doi.org\/10.1002\/ardp.201700028,.","DOI":"10.1002\/ardp.201700028"},{"key":"10.1016\/j.jmgm.2026.109394_bib63","doi-asserted-by":"crossref","unstructured":"Kumar V., et al., Synthesis of some aroylhydrazones and 2, 5-disubstituted-1, 3, 4-oxadiazoles as DNA photocleaving agents, Med. Chem. 6 474-485, https:\/\/doi.org\/10.4172\/2161-0444.1000386,.","DOI":"10.4172\/2161-0444.1000386"},{"key":"10.1016\/j.jmgm.2026.109394_bib64","doi-asserted-by":"crossref","unstructured":"Kumar M., Kumar V., Beniwal V., Synthesis of some pyrazolylaldehyde N-isonicotinoyl hydrazones and 2, 5-disubstituted 1, 3, 4-oxadiazoles as DNA photocleaving agents, Med. Chem. Res. 24 2862-2870, https:\/\/doi.org\/10.1007\/s00044-015-1340-x,.","DOI":"10.1007\/s00044-015-1340-x"},{"key":"10.1016\/j.jmgm.2026.109394_bib65","doi-asserted-by":"crossref","unstructured":"Pan J., et al., Exploring synergistic inhibitory mechanisms of flavonoid mixtures on \u03b1-glucosidase by experimental analysis and molecular dynamics simulation, Food Chem. 464 141560, https:\/\/doi.org\/10.1016\/j.foodchem.2024.141560,.","DOI":"10.1016\/j.foodchem.2024.141560"},{"key":"10.1016\/j.jmgm.2026.109394_bib66","doi-asserted-by":"crossref","unstructured":"Ghomi M. K., et al., Evaluation of novel 2-(quinoline-2-ylthio) acetamide derivatives linked to diphenyl-imidazole as \u03b1-glucosidase inhibitors: insights from in silico, in vitro, and in vivo studies on their anti-diabetic properties, Eur. J. Med. Chem. 269 116332, https:\/\/doi.org\/10.1016\/j.ejmech.2024.116332,.","DOI":"10.1016\/j.ejmech.2024.116332"},{"key":"10.1016\/j.jmgm.2026.109394_bib67","doi-asserted-by":"crossref","unstructured":"Singh G., Singh R., Monga V., Mehan S., 3, 5-Disubstituted-thiazolidine-2, 4-dione hybrids as antidiabetic agents: design, synthesis, in-vitro and in vivo evaluation, Eur. J. Med. Chem. 266 116139, https:\/\/doi.org\/10.1016\/j.ejmech.2024.116139,.","DOI":"10.1016\/j.ejmech.2024.116139"},{"key":"10.1016\/j.jmgm.2026.109394_bib68","doi-asserted-by":"crossref","unstructured":"Talab F., et al., Bio-oriented synthesis of novel polyhydroquinoline derivatives as \u03b1-glucosidase inhibitor for management of diabetes, ACS Omega 8 (7) 6234-6243, https:\/\/doi.org\/10.1021\/acsomega.2c05390,.","DOI":"10.1021\/acsomega.2c05390"},{"key":"10.1016\/j.jmgm.2026.109394_bib69","doi-asserted-by":"crossref","unstructured":"Khan H., et al., Design, synthesis, molecular docking study, and \u03b1-glucosidase inhibitory evaluation of novel hydrazide\u2013hydrazone derivatives of 3, 4-dihydroxyphenylacetic acid, Sci. Rep. 14 (1) 11410, https:\/\/doi.org\/10.1038\/s41598-024-62034-x,.","DOI":"10.1038\/s41598-024-62034-x"},{"key":"10.1016\/j.jmgm.2026.109394_bib70","doi-asserted-by":"crossref","unstructured":"Ali Z., et al., New 1, 3, 4-thiadiazole derivatives as \u03b1-glucosidase inhibitors: design, synthesis, DFT, ADME, and in vitro enzymatic studies, ACS Omega 9 (7) 7480-7490, https:\/\/doi.org\/10.1021\/acsomega.3c05854,.","DOI":"10.1021\/acsomega.3c05854"},{"key":"10.1016\/j.jmgm.2026.109394_bib71","doi-asserted-by":"crossref","unstructured":"Ali M., et al., Synthesis, in vitro \u03b1-glucosidase inhibitory activity, and in silico study of (E)-thiosemicarbazones and (E)-2-(2-(arylmethylene) hydrazinyl)-4-arylthiazole derivatives, Mol. Divers. 22 (4) 841-861, https:\/\/doi.org\/10.1007\/s11030-018-9835-2,.","DOI":"10.1007\/s11030-018-9835-2"},{"issue":"7","key":"10.1016\/j.jmgm.2026.109394_bib72","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1080\/07391102.2022.2040592","article-title":"New styrylquinoxaline: synthesis, structural, biological evaluation, ADMET prediction and molecular docking investigations","volume":"41","author":"Mortada","year":"2023","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326001208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326001208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:11:02Z","timestamp":1780557062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326326001208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":72,"alternative-id":["S1093326326001208"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109394","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of novel quinoxaline linked oxadiazole derivatives as \u03b1-glucosidase inhibitors through homology modelling based in silico screening and in vitro evaluation","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109394"}}